Healio It has been established in previous studies that zoledronic acid improves bone density and reduces risk for fracture. However, new data suggests it may also sig...
OncLive The survival benefit was preserved both with and without current use of bisphosphonates and with and without prior use of docetaxel . Radium-223 significantly prolonged time to first SRE (median, 15.6 months in the treatment arm vs 9.8 months for ...
Wall Street Journal (press release) The increase was driven by $21.3 million in revenue from the launch of 32 new codes or presentations of 16 new products since March 31, 2012, including Zoledronic acid at market formation. Gross profit for the first quarter of 2013 was $18.5 million ... and more »
Healio It has been established in previous studies that zoledronic acid improves bone density and reduces risk for fracture. However, new data suggests it may also sig...
Healio It has been established in previous studies that zoledronic acid improves bone density and reduces risk for fracture. However, new data suggests it may also sig...
Healio It has been established in previous studies that zoledronic acid improves bone density and reduces risk for fracture. However, new data suggests it may also sig...
Healio It has been established in previous studies that zoledronic acid improves bone density and reduces risk for fracture. However, new data suggests it may also sig...
MarketWatch The increase was driven by $21.3 million in revenue from the launch of 32 new codes or presentations of 16 new products since March 31, 2012, including Zoledronic acid at market formation. Gross profit for the first quarter of 2013 was $18.5 million ... and more »
Healio It has been established in previous studies that zoledronic acid improves bone density and reduces risk for fracture. However, new data suggests it may also sig...
MedPage Today Since 2010, four new therapies for CRPC have been approved: abiraterone (Zytiga), sipuleucel-T (Provenge), cabazitaxel (Jevtana), and enzalutamide (Xtandi)...
